Mankind's first natural stem cell transplant

Journal of Cellular and Molecular Medicine

Volumn 14, Issue 3, 2010, Pages 488-495

  Tolosa, Jose N ^a   Park, Dong Hyuk ^a,b   Eve, David J ^a   Klasko, Stephen K ^a   Borlongan, Cesario V ^a   Sanberg, Paul R ^a,c  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b Korea University Ansan Hospital   (South Korea)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Anaemia; Birth; Delayed cord clamping; Preterm; Stem cells; Umbilical cord blood

Indexed keywords

ARTICLE; CORD BLOOD STEM CELL TRANSPLANTATION; FEMALE; HUMAN; LIGATION; METHODOLOGY; NEWBORN; PERINATAL CARE; PREGNANCY; TIME; UMBILICAL CORD; VASCULARIZATION;

CONSTRICTION; CORD BLOOD STEM CELL TRANSPLANTATION; FEMALE; HUMANS; INFANT, NEWBORN; PERINATAL CARE; PREGNANCY; TIME FACTORS; UMBILICAL CORD;

EID: 77953489564     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2010.01029.x     Document Type: Article

References (106)

1. Peltonen T. Placental transfusion - advantage an disadvantage. Eur J Pediatr. 1981, 137:141-6.
2. Mercer JS. Current best evidence: a review of the literature on umbilical cord clamping. J Midwifery Womens Health. 2001, 46:402-14.
3. McClausland AM, Holmes F, Schumann WR. Management of cord and placental blood and its effect upon the newborn. Part II. West J Surg Obstet Gynecol. 1950, 58:591-608.
4. Mercer JS, Nelson CC, Skovgaard RL. Umbilical cord clamping: beliefs and practices of American nurse-midwives. J Midwifery Womens Health. 2000, 45:58-66.
5. McDonald SJ, Middleton P. Effect of timing of umbilical cord clamping of term infants on matenal and neonatal outcomes. Cochrane Database Syst Rev 2008, CD004074.
6. Rabe H, Reynolds G, Diaz-Rossello J. Early versus delayed umbilical cord clamping in preterm infants. Cochrane Database Syst Rev 2004, CD003248.
7. Capasso L, Raimondi F, Capasso A. Early cord clamping protects at-risk neonates from polycythemia. Biol Neonate. 2003, 83:197-200.
8. Diaz-Rossello JL. Early umbilical cord clamping and cord-blood banking. Lancet 2006, 368:840.
9. Hutchon DJ. Commercial cord blood banking: immediate cord clamping is not safe. BMJ 2006, 333:919.
10. Levy T, Blickstein I. Timing of cord clamping revisited. J Perinat Med. 2006, 34:293-7.
11. Glader BE. Red blood cell aplasias in children. Pediatr Ann 1990, 19:73-6.
12. Schiffman JD. The benefits of cord blood collection. Neoreviews 2006, 7:e564-6.
13. Usher RH, Saigal S, O'Neil A. Estimation of red blood cell volume in premature infants with and without respiratory distress syndrome. Biol Neonate. 1975, 26:241-8.
14. Yao AC, Wist A, Lind J. The blood volume of the newborn infant delivered by caesarean section. Acta Paediatr Scand. 1967, 56:585-92.
15. Yao AC, Lind J. Effect of gravity on placental transfusion. Lancet. 1969, 2:505-8.
16. Yao AC, Hirvensalo M, Lind J. Placental transfusion-rate and uterine contraction. Lancet. 1968, 1:380-3.
17. Aladangady N, McHugh S, Aitchison TC. Infants' blood volume in a controlled trial of placental transfusion at preterm delivery. Pediatrics. 2006, 117:93-8.
18. Linderkamp O. Placental transfusion: determinants and effects. Clin Perinatol. 1982, 9:559-92.
19. Nelle M, Zilow EP, Bastert G. Effect of Leboyer childbirth on cardiac output, cerebral and gastrointestinal blood flow velocities in full-term neonates. Am J Perinatol. 1995, 12:212-6.
20. Papile LA, Rudolph AM, Heymann MA. Autoregulation of cerebral blood flow in the preterm fetal lamb. Pediatr Res. 1985, 19:159-61.
21. Mercer J, Erickson-Owens D. Delayed cord clamping increases infants' iron stores. Lancet. 2006, 367:1956-8.
22. Strauss RG, Mock DM, Johnson KJ. A randomized clinical trial comparing immediate versus delayed clamping of the umbilical cord in preterm infants: short-term clinical and laboratory endpoints. Transfusion. 2008, 48:658-65.
23. Baenziger O, Stolkin F, Keel M. The influence of the timing of cord clamping on postnatal cerebral oxygenation in preterm neonates: a randomized, controlled trial. Pediatrics. 2007, 119:455-9.
24. Rabe H, Reynolds G, Diaz-Rossello J. A systematic review and meta-analysis of a brief delay in clamping the umbilical cord of preterm infants. Neonatology. 2008, 93:138-44.
25. Hutton EK, Hassan ES. Late vs early clamping of the umbilical cord in full-term neonates: systematic review and meta-analysis of controlled trials. Jama. 2007, 297:1241-52.
26. Ceriani Cernadas JM, Carroli G, Pellegrini L. The effect of timing of cord clamping on neonatal venous hematocrit values and clinical outcome at term: a randomized, controlled trial. Pediatrics 2006, 117:e779-86.
27. Chaparro CM, Neufeld LM, Tena Alavez G. Effect of timing of umbilical cord clamping on iron status in Mexican infants: a randomised controlled trial. Lancet. 2006, 367:1997-2004.
28. Emhamed MO, van Rheenen P, Brabin BJ. The early effects of delayed cord clamping in term infants born to Libyan mothers. Trop Doct. 2004, 34:218-22.
29. Gupta R, Ramji S. Effect of delayed cord clamping on iron stores in infants born to anemic mothers: a randomized controlled trial. Indian Pediatr. 2002, 39:130-5.
30. Grajeda R, Perez-Escamilla R, Dewey KG. Delayed clamping of the umbilical cord improves hematologic status of Guatemalan infants at 2 mo of age. Am J Clin Nutr. 1997, 65:425-31.
31. van Rheenen P, Brabin BJ. Late umbilical cord-clamping as an intervention for reducing iron deficiency anaemia in term infants in developing and industrialised countries: a systematic review. Ann Trop Paediatr. 2004, 24:3-16.
32. Bonnar J, McNicol GP, Douglas AS. The blood coagulation and fibrinolytic systems in the newborn and the mother at birth. J Obstet Gynaecol Br Commonw. 1971, 78:355-60.
33. Yao AC, Moinian M, Lind J. Distribution of blood between infant and placenta after birth. Lancet. 1969, 2:871-3.
34. Wall DA. Issues in the quality of umbilical cord blood stem cells for transplantation: challenges in cord blood banking quality management. Transfusion. 2005, 45:826-8.
35. Diaz-Rossello JL. International perspectives: cord clamping for stem cell donation: medical facts and ethics. Neoreviews 2006, 7:e557-63.
36. Erices A, Conget P, Minguell JJ. Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol. 2000, 109:235-42.
37. Berger MJ, Adams SD, Tigges BM. Differentiation of umbilical cord blood-derived multilineage progenitor cells into respiratory epithelial cells. Cytotherapy. 2006, 8:480-7.
38. Kim JW, Kim SY, Park SY. Mesenchymal progenitor cells in the human umbilical cord. Ann Hematol. 2004, 83:733-8.
39. Todaro AM, Pafumi C, Pernicone G. Haematopoietic progenitors from umbilical cord blood. Blood Purif. 2000, 18:144-7.
40. Nayar B, Raju GM, Deka D. Hematopoietic stem/progenitor cell harvesting from umbilical cord blood. Int J Gynaecol Obstet. 2002, 79:31-2.
41. Broxmeyer HE, Hangoc G, Cooper S. Growth characteristics and expansion of human umbilical cord blood and estimation of its potential for transplantation in adults. Proc Natl Acad Sci USA. 1992, 89:4109-13.
42. Vaziri H, Dragowska W, Allsopp RC. Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc Natl Acad Sci USA. 1994, 91:9857-60.
43. Nakahata T, Ogawa M. Hemopoietic colony-forming cells in umbilical cord blood with extensive capability to generate mono- and multipotential hemopoietic progenitors. J Clin Invest. 1982, 70:1324-8.
44. Frassoni F, Podesta M, Maccario R. Cord blood transplantation provides better reconstitution of hematopoietic reservoir compared with bone marrow transplantation. Blood. 2003, 102:1138-41.
45. Sirchia G, Rebulla P. Placental/umbilical cord blood transplantation. Haematologica. 1999, 84:738-47.
46. Pranke P, Failace RR, Allebrandt WF. Hematologic and immunophenotypic characterization of human umbilical cord blood. Acta Haematol. 2001, 105:71-6.
47. Harris DT, Schumacher MJ, Locascio J. Phenotypic and functional immaturity of human umbilical cord blood T lymphocytes. Proc Natl Acad Sci USA. 1992, 89:10006-10.
48. Hirose Y, Kiyoi H, Itoh K. B-cell precursors differentiated from cord blood CD34+ cells are more immature than those derived from granulocyte colony-stimulating factor-mobilized peripheral blood CD34+ cells. Immunology. 2001, 104:410-7.
49. D'Arena G, Musto P, Cascavilla N. Flow cytometric characterization of human umbilical cord blood lymphocytes: immunophenotypic features. Haematologica. 1998, 83:197-203.
50. Zola H, Fusco M, Macardle PJ. Expression of cytokine receptors by human cord blood lymphocytes: comparison with adult blood lymphocytes. Pediatr Res. 1995, 38:397-403.
51. Gluckman E, Rocha V. History of the clinical use of umbilical cord blood hematopoietic cells. Cytotherapy. 2005, 7:219-27.
52. Rainsford E, Reen DJ. Interleukin 10, produced in abundance by human newborn T cells, may be the regulator of increased tolerance associated with cord blood stem cell transplantation. Br J Haematol. 2002, 116:702-9.
53. Buelens C, Willems F, Delvaux A. Interleukin-10 differentially regulates B7-1 (CD80) and B7-2 (CD86) expression on human peripheral blood dendritic cells. Eur J Immunol. 1995, 25:2668-72.
54. Asseman C, Powrie F. Interleukin 10 is a growth factor for a population of regulatory T cells. Gut. 1998, 42:157-8.
55. Jiang Q, Azuma E, Hirayama M. Functional immaturity of cord blood monocytes as detected by impaired response to hepatocyte growth factor. Pediatr Int. 2001, 43:334-9.
56. Theilgaard-Monch K, Raaschou-Jensen K, Palm H. Flow cytometric assessment of lymphocyte subsets, lymphoid progenitors, and hematopoietic stem cells in allogeneic stem cell grafts. Bone Marrow Transplant. 2001, 28:1073-82.
57. Liu E, Tu W, Law HK. Decreased yield, phenotypic expression and function of immature monocyte-derived dendritic cells in cord blood. Br J Haematol. 2001, 113:240-6.
58. Willing AE, Eve DJ, Sanberg PR. Umbilical cord blood transfusions for prevention of progressive brain injury and induction of neural recovery: an immunological perspective. Regen Med. 2007, 2:457-64.
59. Arpinati M, Green CL, Heimfeld S. Granulocytecolony stimulating factor mobilizes T helper 2-inducing dendritic cells. Blood. 2000, 95:2484-90.
60. El Marsafy S, Dosquet C, Coudert MC. Study of cord blood natural killer cell suppressor activity. Eur J Haematol. 2001, 66:215-20.
61. Dalle JH, Menezes J, Wagner E. Characterization of cord blood natural killer cells: implications for transplantation and neonatal infections. Pediatr Res. 2005, 57:649-55.
62. Chen N, Hudson JE, Walczak P. Human umbilical cord blood progenitors: the potential of these hematopoietic cells to become neural. Stem Cells. 2005, 23:1560-70.
63. Ding DC, Shyu WC, Chiang MF. Enhancement of neuroplasticity through upregulation of beta1-integrin in human umbilical cord-derived stromal cell implanted stroke model. Neurobiol Dis. 2007, 27:339-53.
64. Goodwin HS, Bicknese AR, Chien SN. Multilineage differentiation activity by cells isolated from umbilical cord blood: expression of bone, fat, and neural markers. Biol Blood Marrow Transplant. 2001, 7:581-8.
65. Yang SE, Ha CW, Jung M. Mesenchymal stem/progenitor cells developed in cultures from UC blood. Cytotherapy. 2004, 6:476-86.
66. Jeong JA, Gang EJ, Hong SH. Rapid neural differentiation of human cord blood-derived mesenchymal stem cells. Neuroreport. 2004, 15:1731-4.
67. Lee KD, Kuo TK, Whang-Peng J. In vitro hepatic differentiation of human mesenchymal stem cells. Hepatology. 2004, 40:1275-84.
68. Kosmacheva SM, Volk MV, Yeustratenka TA. In vitro growth of human umbilical blood mesenchymal stem cells and their differentiation into chondrocytes and osteoblasts. Bull Exp Biol Med. 2008, 145:141-5.
69. El-Badri NS, Hakki A, Saporta S. Cord blood mesenchymal stem cells: potential use in neurological disorders. Stem Cells Dev. 2006, 15:497-506.
70. Ende M, Ende N. Hematopoietic transplantation by means of fetal (cord) blood. Virginia Med Mon. 1972, 99:276-80.
71. Gluckman E, Broxmeyer HA, Auerbach AD. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med. 1989, 321:1174-8.
72. Escolar ML, Poe MD, Provenzale JM. Transplantation of umbilical-cord blood in babies with infantile Krabbe's disease. N Engl J Med. 2005, 352:2069-81.
73. Hall JG, Martin PL, Wood S. Unrelated umbilical cord blood transplantation for an infant with beta-thalassemia major. J Pediatr Hematol Oncol. 2004, 26:382-5.
74. Kelly P, Kurtzberg J, Vichinsky E. Umbilical cord blood stem cells: application for the treatment of patients with hemoglobinopathies. J Pediatr. 1997, 130:695-703.
75. Krivit W, Shapiro EG, Peters C. Hematopoietic stem-cell transplantation in globoid-cell leukodystrophy. N Engl J Med. 1998, 338:1119-27.
76. Locatelli F, Rocha V, Reed W. Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease. Blood. 2003, 101:2137-43.
77. Myers LA, Hershfield MS, Neale WT. Purine nucleoside phosphorylase deficiency (PNP-def) presenting with lymphopenia and developmental delay: successful correction with umbilical cord blood transplantation. J Pediatr. 2004, 145:710-2.
78. Staba SL, Escolar ML, Poe M. Cord-blood transplants from unrelated donors in patients with Hurler's syndrome. N Engl J Med. 2004, 350:1960-9.
79. Fruchtman SM, Hurlet A, Dracker R. The successful treatment of severe aplastic anemia with autologous cord blood transplantation. Biol Blood Marrow Transplant. 2004, 10:741-2.
80. Rocha V, Cornish J, Sievers EL. Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood. 2001, 97:2962-71.
81. Rocha V, Labopin M, Sanz G. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med. 2004, 351:2276-85.
82. Wall DA, Carter SL, Kernan NA. Busulfan/melphalan/antithymocyte globulin followed by unrelated donor cord blood transplantation for treatment of infant leukemia and leukemia in young children: the Cord Blood Transplantation study (COBLT) experience. Biol Blood Marrow Transplant. 2005, 11:637-46.
83. Newcomb JD, Sanberg PR, Klasko SK. Umbilical cord blood research: current and future perspectives. Cell Transplant. 2007, 16:151-8.
84. Rocha V, Wagner JE, Sobocinski KA. Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources. N Engl J Med. 2000, 342:1846-54.
85. Rocha V, Cornish J, Sievers EL. Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood. 2001, 97:2962-71.
86. Vendrame M, Cassady J, Newcomb J. Infusion of human umbilical cord blood cells in a rat model of stroke dose-dependently rescues behavioral deficits and reduces infarct volume. Stroke. 2004, 35:2390-5.
87. Newcomb JD, Ajmo CT, Sanberg CD. Timing of cord blood treatment after experimental stroke determines therapeutic efficacy. Cell Transplant. 2006, 15:213-23.
88. Newman MB, Willing AE, Manresa JJ. Stroke-induced migration of human umbilical cord blood cells: time course and cytokines. Stem Cells Dev. 2005, 14:576-86.
89. Park DH, Borlongan CV, Willing AE. Human umbilical cord blood cell grafts for brain ischemia. Cell Transplant. 2009, 18:985-98.
90. Newman MB, Willing AE, Manresa JJ. Cytokines produced by cultured human umbilical cord blood (HUCB) cells: implications for brain repair. Exp Neurol. 2006, 199:201-8.
91. Taguchi A, Soma T, Tanaka H. Administration of CD34+ cells after stroke enhances neurogenesis via angiogenesis in a mouse model. J Clin Invest. 2004, 114:330-8.
92. Vendrame M, Gemma C, de Mesquita D. Anti-inflammatory effects of human cord blood cells in a rat model of stroke. Stem Cells Dev. 2005, 14:595-604.
93. Garbuzova-Davis S, Gografe SJ, Sanberg CD. Maternal transplantation of human umbilical cord blood cells provides prenatal therapy in Sanfilippo type B mouse model. FASEB J. 2006, 20:485-7.
94. Garbuzova-Davis S, Willing AE, Desjarlais T. Transplantation of human umbilical cord blood cells benefits an animal model of Sanfilippo syndrome type B. Stem Cells Dev. 2005, 14:384-94.
95. Garbuzova-Davis S, Xie Y, Zayko O. Human umbilical cord blood cells in treatment of Sanfilippo syndrome type B. Cell Transplant. 2009, 18:214-5.
96. Meier C, Middelanis J, Wasielewski B. Spastic paresis after perinatal brain damage in rats is reduced by human cord blood mononuclear cells. Pediatr Res. 2006, 59:244-9.
97. Merkle FT, Alvarez-Buylla A. Neural stem cells in mammalian development. Curr Opin Cell Biol. 2006, 18:704-9.
98. Borok Z, Li C, Liebler J. Developmental pathways and specification of intrapulmonary stem cells. Pediatr Res 2006, 59:84R-93R.
99. Garry DJ, Olson EN. A common progenitor at the heart of development. Cell. 2006, 127:1101-4.
100. Dieterlen-Lievre F. Emergence of haematopoietic stem cells during development. C R Biol. 2007, 330:504-9.
101. Bhandoola A, von Boehmer H, Petrie HT. Commitment and developmental potential of extrathymic and intrathymic T cell precursors: plenty to choose from. Immunity. 2007, 26:678-89.
102. Murtaugh LC. Pancreas and beta-cell development: from the actual to the possible. Development. 2007, 134:427-38.
103. Haneline LS, Marshall KP, Clapp DW. The highest concentration of primitive hematopoietic progenitor cells in cord blood is found in extremely premature infants. Pediatr Res. 1996, 39:820-5.
104. Mercer JS, Vohr BR, McGrath MM. Delayed cord clamping in very preterm infants reduces the incidence of intraventricular hemorrhage and late-onset sepsis: a randomized, controlled trial. Pediatrics. 2006, 117:1235-42.
105. Marumo G, Kozuma S, Ohyu J. Generation of periventricular leukomalacia by repeated umbilical cord occlusion in near-term fetal sheep and its possible pathogenetical mechanisms. Biol Neonate. 2001, 79:39-45.
106. Mercer JS, Vohr BR, Erickson-Owens DA. Seven-month developmental outcomes of very low birth weight infants enrolled in a randomized controlled trial of delayed versus immediate cord clamping. J Perinatol. 2010, 30:11-6.